Search

Your search keyword '"Khan, Mansoor A."' showing total 56 results

Search Constraints

Start Over You searched for: Author "Khan, Mansoor A." Remove constraint Author: "Khan, Mansoor A." Publisher elsevier Remove constraint Publisher: elsevier
56 results on '"Khan, Mansoor A."'

Search Results

5. Contributors

6. Contributors

8. List of Contributors

10. Nanotechnology-based drug products

11. List of Contributors

12. In-Situ Implant Formulation of Laurate and Myristate Prodrugs of Dolutegravir for Ultra-Long Delivery.

13. Development and Validation Of A Discriminatory Dissolution Method for Portioned Moist Snuff and Snus.

14. Fractionated charge variants of biosimilars: A review of separation methods, structural and functional analysis.

15. Ultrasound-guided versus blind vascular access followed by REBOA on board of a medical helicopter in a hemorrhagic ovine model.

16. Development of Methamphetamine Abuse-Deterrent Formulations Using Sucrose Acetate Isobutyrate.

17. Univariate and Multivariate Models for Determination of Prasugrel Base in the Formulation of Prasugrel Hydrochloride Using XRPD Method.

18. Development and Validation of a Discriminatory Dissolution Method for Rifaximin Products.

19. Quality and In-Use Stability Comparison of Brand and Generics of Extended-Release Phenytoin Sodium Capsules.

20. Chemometric Models for Quantification of Carbamazepine Anhydrous and Dihydrate Forms in the Formulation.

21. A meta-analysis of the efficacy of whole-body computed tomography imaging in the management of trauma and injury.

22. Evaluation of the In Vitro Efficacy of Sevelamer Hydrochloride and Sevelamer Carbonate.

23. Managing a Rare Malignant Sweat Gland Tumor Invading the Brain: Case Report and Literature Review.

24. Spectroscopic-Based Chemometric Models for Quantifying Low Levels of Solid-State Transitions in Extended Release Theophylline Formulations.

25. Evaluation of In-Use Stability of Anticoagulant Drug Products: Warfarin Sodium.

26. Chemometric Model Development and Comparison of Raman and (13)C Solid-State Nuclear Magnetic Resonance-Chemometric Methods for Quantification of Crystalline/Amorphous Warfarin Sodium Fraction in the Formulations.

27. Comparison of X-ray powder diffraction and solid-state nuclear magnetic resonance in estimating crystalline fraction of tacrolimus in sustained-release amorphous solid dispersion and development of discriminating dissolution method.

28. Chemometric methods for the quantification of crystalline tacrolimus in solid dispersion by powder X-ray diffractrometry.

29. Near-infrared and fourier transform infrared chemometric methods for the quantification of crystalline tacrolimus from sustained-release amorphous solid dispersion.

30. An integrated process analytical technology (PAT) approach to monitoring the effect of supercooling on lyophilization product and process parameters of model monoclonal antibody formulations.

31. Stereomicroscopic imaging technique for the quantification of cold flow in drug-in-adhesive type of transdermal drug delivery systems.

32. Analytical methods for the evaluation of melamine contamination.

33. Characterization of a nonribosomal peptide antibiotic solid dispersion formulation by process analytical technologies sensors.

34. Chemometric evaluation of near infrared, fourier transform infrared, and Raman spectroscopic models for the prediction of nimodipine polymorphs.

35. Development and evaluation of paclitaxel nanoparticles using a quality-by-design approach.

36. Oseltamivir phosphate-amberlite(TM) IRP 64 ionic complex for taste masking: preparation and chemometric evaluation.

37. Process analytical technology to understand the disintegration behavior of alendronate sodium tablets.

38. Comparative evaluation of the in vitro efficacy of lanthanum carbonate chewable tablets.

39. Spontaneous carbonate formation in an amorphous, amine-rich, polymeric drug substance: sevelamer HCl product quality.

40. Chemometric evaluation of brompheniramine-tannate complexes.

41. Quality-by-design: an integrated process analytical technology approach to determine the nucleation and growth mechanisms during a dynamic pharmaceutical coprecipitation process.

42. Quality-by-Design (QbD): an integrated process analytical technology (PAT) approach for real-time monitoring and mapping the state of a pharmaceutical coprecipitation process.

43. Spectral and spatial characterization of protein loaded PLGA nanoparticles.

44. Thermodynamic stability assessment of a colloidal iron drug product: sodium ferric gluconate.

45. Quality-by-design (QbD): an integrated approach for evaluation of powder blending process kinetics and determination of powder blending end-point.

46. Robust calibration design in the pharmaceutical quantitative measurements with near-infrared (NIR) spectroscopy: Avoiding the chemometric pitfalls.

47. Functionality of magnesium stearate derived from bovine and vegetable sources: dry granulated tablets.

48. Quality-by-design (QbD): effects of testing parameters and formulation variables on the segregation tendency of pharmaceutical powder measured by the ASTM D 6940-04 segregation tester.

49. Process analytical technology: nondestructive evaluation of cyclosporine A and phospholipid solid dispersions by near infrared spectroscopy and imaging.

50. Process analytical technology (PAT): quantification approaches in terahertz spectroscopy for pharmaceutical application.

Catalog

Books, media, physical & digital resources